BTN3A3 can bind to FGF2, regulate the protein level of FGF2, and then regulate the phosphorylation level of ERK1/2, thus affecting the proliferation, migration and invasion of ovarian cancer cells. The gene discussed is MAPK3; the disease is ovarian carcinoma.